These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23290735)

  • 1. Diabetes management in the kidney patient.
    Garg R; Williams ME
    Med Clin North Am; 2013 Jan; 97(1):135-56. PubMed ID: 23290735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic management in ESRD and earlier stages of CKD.
    Williams ME; Garg R
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S22-38. PubMed ID: 24461727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy in the management of type 1 and type 2 diabetes.
    Wallymahmed M
    Nurs Stand; 2006 Oct 18-24; 21(6):50-6; quiz 58. PubMed ID: 17069159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [[GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE – HOW TO CHOOSE HYPOGLYCEMIC AGENT]?].
    Baretić M; Lang VB
    Acta Med Croatica; 2016 Dec; 70(4-5):269-74. PubMed ID: 29087153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of type 2 diabetes mellitus in patients with chronic kidney disease. Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica].
    Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
    Med Clin (Barc); 2014 Jan; 142(2):85.e1-10. PubMed ID: 24268912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia, chronic kidney disease, and diabetes mellitus.
    Alsahli M; Gerich JE
    Mayo Clin Proc; 2014 Nov; 89(11):1564-71. PubMed ID: 25305751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
    Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGLT-2 inhibition in patients with kidney disease.
    Gilbert RE
    Diabetes Metab; 2014 Dec; 40(6 Suppl 1):S23-7. PubMed ID: 25554068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].
    Füessl HS
    MMW Fortschr Med; 2005 Aug; 147(31-32):4-6, 8. PubMed ID: 16128187
    [No Abstract]   [Full Text] [Related]  

  • 12. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
    Sloan LA
    J Diabetes; 2019 Dec; 11(12):938-948. PubMed ID: 31318152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.
    Betônico CC; Titan SMO; Lira A; Pelaes TS; Correa-Giannella MLC; Nery M; Queiroz M
    Clin Ther; 2019 Oct; 41(10):2008-2020.e3. PubMed ID: 31383366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Kidney and SGLT2 Inhibitors in Type 2 Diabetes.
    Katz PM; Leiter LA
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S167-75. PubMed ID: 26654860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes management issues for patients with chronic kidney disease].
    Oulahiane A; Anaddam S; Ouleghzal H; Elhaddad N; Moussaoui S; Yaagoubi N; Boufares F; Belmejdoub G
    Nephrol Ther; 2012 Jun; 8(3):135-40. PubMed ID: 22015216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical contribution of new basal analogue insulin].
    Adamíková A
    Vnitr Lek; 2016; 62(7-8):534-8. PubMed ID: 27627074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.
    Betônico CC; Titan SM; Correa-Giannella ML; Nery M; Queiroz M
    Clinics (Sao Paulo); 2016 Jan; 71(1):47-53. PubMed ID: 26872083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring glycemia in diabetes.
    Healy SJ; Dungan KM
    Med Clin North Am; 2015 Jan; 99(1):35-45. PubMed ID: 25456642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
    Tong L; Adler S
    Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.